219 related articles for article (PubMed ID: 19051606)
1. Comparison of sublingual tablets with nitroglycerin complexed with beta-cyclodextrin or titrated with crosspovidone--technological approach.
Centkowska K; Sznitowska M
Acta Pol Pharm; 2008; 65(5):585-9. PubMed ID: 19051606
[TBL] [Abstract][Full Text] [Related]
2. Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
Centkowska K; Sznitowska M
J Pharm Pharmacol; 2013 Oct; 65(10):1463-72. PubMed ID: 24028613
[TBL] [Abstract][Full Text] [Related]
3. Potency and stability of extemporaneous nitroglycerin infusions.
McNiff BL; McNiff EF; Fung HL
Am J Hosp Pharm; 1979 Feb; 36(2):173-7. PubMed ID: 105634
[TBL] [Abstract][Full Text] [Related]
4. Optimal starting time of acquisition and feasibility of complementary administration of nitroglycerin with intravenous beta-blocker in multislice computed tomography.
Sato K; Isobe S; Sugiura K; Mimura T; Yotsudake Y; Meno C; Kato M; Harada K; Murohara T
J Comput Assist Tomogr; 2009; 33(2):193-8. PubMed ID: 19346844
[TBL] [Abstract][Full Text] [Related]
5. [Study on the inclusion technology of volatile oil in Shiquandabu pills].
Xu HX; Liu XP; Gong YX
Zhong Yao Cai; 2007 Jul; 30(7):861-2. PubMed ID: 17944202
[TBL] [Abstract][Full Text] [Related]
6. Open-Label Study of the Stability of Sublingual Nitroglycerin Tablets in Simulated Real-Life Conditions.
Nawarskas JJ; Koury J; Lauber DA; Felton LA
Am J Cardiol; 2018 Dec; 122(12):2151-2156. PubMed ID: 30314813
[TBL] [Abstract][Full Text] [Related]
7. Optimization of promethazine theoclate fast dissolving tablet using pore forming technology by 3-factor, 3-level response surface-full factorial design.
Sharma S; Sharma N; Das Gupta G
Arch Pharm Res; 2010 Aug; 33(8):1199-207. PubMed ID: 20803123
[TBL] [Abstract][Full Text] [Related]
8. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
Krajnyák J; Rácz I; Dávid A; Szejtli J
Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
[No Abstract] [Full Text] [Related]
9. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
[No Abstract] [Full Text] [Related]
10. [Development of an oral nitroglycerin proxyphyllin retard compound].
Ritschel WA; Clotten R
Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
[No Abstract] [Full Text] [Related]
11. Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope.
Foglia-Manzillo G; Giada F; Fteita N; Nessi I; Santarone M; Raviele A
Eur Heart J; 2007 Nov; 28(21):2605-9. PubMed ID: 17911368
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers.
Hiremath AN; Hoffman BB; Blaschke TF
J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766
[TBL] [Abstract][Full Text] [Related]
13. Sublingual nitroglycerin. I. Comparative evaluation of the physical stability of commercially available tablets.
Lagas M; Duchateau AM
Pharm Weekbl Sci; 1988 Dec; 10(6):246-53. PubMed ID: 3145487
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
[TBL] [Abstract][Full Text] [Related]
15. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
Gyulai M; Apostol I
Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
[No Abstract] [Full Text] [Related]
16. Development of a stable sublingual nitroglycerin tablet II: formulation and evaluation of tablets containing povidone.
Fung HL; Yap SK; Rhodes CT
J Pharm Sci; 1976 Apr; 65(4):558-60. PubMed ID: 818363
[TBL] [Abstract][Full Text] [Related]
17. Stability of stabilized nitroglycerin tablets in typical distribution and administration systems.
Dorsch B; Shangraw R
Am J Hosp Pharm; 1975 Aug; 32(8):795-808. PubMed ID: 807102
[TBL] [Abstract][Full Text] [Related]
18. Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets.
Lagas M; Duchateau AM
Pharm Weekbl Sci; 1988 Dec; 10(6):254-8. PubMed ID: 3145488
[TBL] [Abstract][Full Text] [Related]
19. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application.
Treleano A; Wolz G; Brandsch R; Welle F
Int J Pharm; 2009 Mar; 369(1-2):30-7. PubMed ID: 19027840
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch.
Mourtzinos I; Kalogeropoulos N; Papadakis SE; Konstantinou K; Karathanos VT
J Food Sci; 2008 Jan; 73(1):S89-94. PubMed ID: 18211376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
